Literature DB >> 35530369

The current dengue outbreak amidst COVID-19 pandemic in Pakistan; a major threat to Pakistan's healthcare system.

Shahzaib Ahmad1, Fatima Yasin1, Manas Pustake2, Hadin Darain Khan3, Inês F Silva Correia4.   

Abstract

Entities:  

Year:  2022        PMID: 35530369      PMCID: PMC9060710          DOI: 10.1016/j.amsu.2022.103670

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


× No keyword cloud information.
Dear Editor, Pakistan is facing another calamity in the form of a Dengue outbreak which has been surging since the advent of October 2021. Public and private hospitals in the federal capital Islamabad and other cities of Pakistan are under a great burden as this outbreak has struck amidst the COVID-19 pandemic. The situation has become alarming with the recent Dengue surge diverting attention from the COVID-19 pandemic and authorities failing to compile data, resulting in underreporting of cases. The immediate anti-dengue surveillance campaign has shown many hotspots where the Dengue vector is breeding continuously, and an anti-dengue campaign has been launched in the capital as well as in other provinces to cater to this issue. However, under-reporting and a deficiency in surveillance are aggravating the problem [1]. The target of this letter is to highlight this under-reporting and surveillance issue so that the proper interventions can be made for better protection of the population at risk from this lethal outbreak. Moreover, the global attraction to the problem is aimed at preventing its application elsewhere (see Table 1).
Table 1

Comparison of COVID-19 and dengue fever [[2], [3], [4], [5], [6], [7]].

COVID-19Dengue Fever
Clinical FeaturesPrimarily cough and shortness of breathNausea, vomiting, rash, aches and pains (eye pain, typically behind the eyes, muscle, joint or bone pain)
DiagnosisRT-PCRNAAT and Serology
PrognosisVariablePoor
Risk Groups and Risk FactorsClose contact with infected person/ImmunosuppressionAge >6 years, hepatomegaly, abdomen pain and oliguria were the most common risk factors associated with shock in children with Dengue fever
TreatmentSymptomatic (other drugs are under trial)Under Trial
VaccinationUndertrial (WHO has approved several for emergency use)Under development
Comparison of COVID-19 and dengue fever [[2], [3], [4], [5], [6], [7]]. Dengue is an infectious disease caused by any of the four virus serotypes: DENVs [[2], [3], [4], [5]]. It is a mosquito-borne disease and is primarily transmitted to humans by the female Aedes mosquito. It is a daytime breeder, biting the victim early in the morning or just before dark and spreading quickly, with the victim developing a viremia after just 4 days of being bitten by an infected mosquito. The fever arises and subsides in a cyclical pattern and the victim's platelet count starts decreasing. The disease is mainly concentrated in tropical and subtropical regions, putting nearly a third of the human population, worldwide, at risk of infection. Infection with DENV results in varying degrees of pathological conditions, ranging from mild asymptomatic Dengue fever (DF) to severe Dengue hemorrhagic fever (DHF) and Dengue shock syndrome (DSS) which may be fatal. A dramatic worldwide expansion of the DENV has occurred due to rapid urbanisation, an increase in international travel, a lack of effective mosquito control measures and globalisation. Though there is no approved drug, an update by Sanofi Pasteur reveals licensing of its vaccine in Mexico, Brazil, the Philippines and El Salvador [3]. Dengue has been a problem for Pakistan for many years, having faced its first outbreak in 1994 and a sudden increase in human cases in October 2005. Dengue is now an epidemic in Pakistan and many outbreaks have been reported in 2010, 2017, 2019 and 2020. Cases of Dengue fever circulate throughout the year, with a peak incidence occurring in the monsoon season. The 2020 outbreak was amidst a COVID-19 pandemic that resulted in about 3,442 human cases of Dengue fever, leading to a significant threat to Pakistan's healthcare system. Furthermore, the country is now facing another dangerous outbreak of Dengue fever amidst the COVID-19 pandemic [8]. The National Institute of Health (NIH) of Islamabad, Pakistan, has published a report at the end of October 2021 in which it was said there were 25,478 cases of Dengue fever so far this year, with an escalation of almost 22,000 cases in just the past two months [1]. The challenges in combating the Dengue epidemic are many, including limited economic resources, lack of awareness, education, or action, limited community cohesion, limited sustainability of government interventions and an ineffective reporting system and surveillance. A complex combination of economic, environmental, health, political, and social factors can influence an individual's and community's adherence to suggested Dengue prevention strategies, either directly or indirectly [9]. Pakistan's Emergency Plan of Action (EPoA): Dengue Response is currently being enacted to curtail Dengue vector control. This project aims to limit the spread of vector transmission and develop prevention measures among vulnerable groups by providing long-lasting insecticidal nets (LLINs), mosquito repellent, spraying and fumigating mosquito breeding areas while raising community and educational awareness [10]. It is critical that the government investigates the problem before it escalates into a more dangerous situation for these communities, as well as committing adequate funding for preventative measures. Furthermore, an effective system for formal case reports should be in place so that the exact gravity of the situation can be determined quickly. By understanding how these intrinsic and extrinsic factors hinder adherence, health authorities can adopt national policies to strengthen community participatory action in vector control, empower leadership potential among health workers and community members and provide an appropriate and systemic approach to preventing disease transmission. A plan should be fully implemented, and the reaction to the program, as well as beneficiary input, should be analyzed and monitored. The public should be appropriately informed about current and previous epidemics so that they can play an important part in preventing future outbreaks, such as understanding how to seek medical treatment following a fever and avoid aspirin and ibuprofen if sick. Furthermore, the municipality should take proactive measures to keep public spaces and hospitals as clean as possible, while the community is taught on proper waste disposal and the dangers that can result if it is not done. Sources of stagnant water should also be discarded and avoided in order to eliminate the vector's reproductive grounds. All of these methods necessitate community involvement in order for a Dengue awareness program to function effectively through inter-sectoral coordination. The seriousness of the situation has been explained, and this letter is intended to draw the government's attention to the problem while it is still in its early stages. The impact on the health system is significant as the number of severe illnesses rises and more individuals require rapid hospitalization. To protect Pakistan's communities from a future outbreak, guidelines and effective control procedures should be implemented.

Please state any sources of funding for your research

No funding

Ethical approval

Not required.

Consent

NA.

Author contribution

Every author contributed to every stage of paper writing and design.

Registration of research studies

Name of the registry: Unique Identifying number or registration ID: Hyperlink to your specific registration (must be publicly accessible and will be checked):

Guarantor

Fatima Yasin yasinfatima18@gmail.com.

Declaration of competing interest

No conflict of interest.
  8 in total

Review 1.  Dengue vaccine acceptance and willingness to pay.

Authors:  Harapan Harapan; Jonny K Fajar; R Tedjo Sasmono; Ulrich Kuch
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

2.  Clinical features of covid-19.

Authors:  Pauline Vetter; Diem Lan Vu; Arnaud G L'Huillier; Manuel Schibler; Laurent Kaiser; Frederique Jacquerioz
Journal:  BMJ       Date:  2020-04-17

3.  Surveillance of intensity level and geographical spreading of dengue outbreak among males and females in Punjab, Pakistan: A case study of 2011.

Authors:  Shahbaz Ahmad; Muhammad Asif; Ramzan Talib; Muhammad Adeel; Muhammad Yasir; Muhammad H Chaudary
Journal:  J Infect Public Health       Date:  2017-11-02       Impact factor: 3.718

4.  COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes.

Authors:  Sergio Alejandro Gómez-Ochoa; Oscar H Franco; Lyda Z Rojas; Peter Francis Raguindin; Zayne Milena Roa-Díaz; Beatrice Minder Wyssmann; Sandra Lucrecia Romero Guevara; Luis Eduardo Echeverría; Marija Glisic; Taulant Muka
Journal:  Am J Epidemiol       Date:  2021-01-04       Impact factor: 4.897

5.  Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study.

Authors:  Romanee Chaiwarith; Waree Jullaket; Manasanant Bunchoo; Nontakan Nuntachit; Thira Sirisanthana; Khuanchai Supparatpinyo
Journal:  BMC Infect Dis       Date:  2011-05-25       Impact factor: 3.090

6.  Challenges & options in dengue prevention & control: A perspective from the 2015 outbreak.

Authors:  Siddharth Jain; Surendra K Sharma
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

Review 7.  [Dengue fever : Symptoms, epidemiology, entomology, pathogen diagnosis and prevention].

Authors:  D Wiemer; H Frickmann; A Krüger
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

Review 8.  Dengue: A Minireview.

Authors:  Harapan Harapan; Alice Michie; R Tedjo Sasmono; Allison Imrie
Journal:  Viruses       Date:  2020-07-30       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.